Spectral Medical Inc. EDTXF
0.74 USD -0.03 (-4.02%)
At closeNov 10, 2026, 4:00 PM EST
0.76 Day range 0.76
0.638 52-week range 1.10
- YTD
- -28.85%
- 1 year
- -31.48%
News
globenewswire.com Spectral Medical Announces U.S. FDA Filing of PMA Application for PMX TORONTO, June 25, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,…
globenewswire.com Spectral Medical Inc. Announces Results of Annual and Special Meeting of Shareholders TORONTO, June 09, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,…
seekingalpha.com Spectral Medical Inc. (EDT:CA) Shareholder/Analyst Call Transcript Spectral Medical Inc. (EDT:CA) Shareholder/Analyst Call Transcript
globenewswire.com Spectral Medical and Vantive Announce Topline 12 Month Follow-Up Results From Spectral's Tigris Trial 100% follow-up achieved for all 157 patients enrolled in the Tigris trial Mortality at 12 months was 52.8% with PMX vs. 66.7% with standard of care alone (absolute risk reduction of 13.9%; number…
globenewswire.com Spectral Medical Announces PMA Submission to U.S. FDA for PMX TORONTO, May 29, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,…
globenewswire.com Spectral Medical Announces First Quarter 2026 Financial Results and Provides Corporate Update TORONTO, May 08, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,…
newsfilecorp.com Spectral Medical Inc. Announces Participation in the 2026 Bloom Burton & Co. Healthcare Investor Conference Toronto, Ontario--(Newsfile Corp. - April 1, 2026) - Spectral Medical Inc. (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, will be…
globenewswire.com Spectral Medical Announces Fourth Quarter and Fiscal 2025 Results and Provides Corporate Update TORONTO, March 26, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,…
globenewswire.com Spectral Medical and Vantive Announce Publication of Complete Results from Spectral's Tigris Trial in the Lancet Respiratory Medicine TORONTO and DEERFIELD, Ill., March 24, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic…
globenewswire.com Spectral Medical Provides Update on PMA Submission Timing for PMX-20R TORONTO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,…
seekingalpha.com Spectral Medical Inc. (EDT:CA) Discusses Year-End Update: FDA Filing Timeline, Tigris Trial Results, and Commercialization Readiness Transcript Spectral Medical Inc. (EDT:CA) Discusses Year-End Update: FDA Filing Timeline, Tigris Trial Results, and Commercialization Readiness Transcript
defenseworld.net Reviewing SiBone (NASDAQ:SIBN) & Spectral Diagnostics (OTCMKTS:EDTXF) Spectral Diagnostics (OTCMKTS:EDTXF - Get Free Report) and SiBone (NASDAQ: SIBN - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two…
globenewswire.com Spectral Medical Inc. Files Base Shelf Prospectus and Revised AIF TORONTO, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,…
globenewswire.com Spectral Medical Announces Publication of EDEN Observational Study New Study Strengthens Rationale for Spectral's PMX Therapy by Defining Endotoxic Septic Shock (ESS) as the Highest-Risk Patient Group New Study Strengthens Rationale for Spectral's PMX Therapy by…
globenewswire.com Spectral Medical Receives US$3 Million From Vantive TORONTO, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,…
globenewswire.com Spectral Medical and Vantive Announce Topline Results from Spectral's Tigris Trial Evaluating PMX Hemoadsorption Therapy for Endotoxic Septic Shock TORONTO, Ontario and DEERFIELD, Ill., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and…
globenewswire.com Spectral Medical Announces Second Quarter and Provides Corporate Update TORONTO, Aug. 08, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,…
globenewswire.com Spectral Medical Inc. Announces Filing of Base Shelf Prospectus TORONTO, July 04, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,…
globenewswire.com Spectral Medical Inc. Announces Results of Annual Meeting of Shareholders TORONTO, June 06, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,…
benzinga.com Stocks That Hit 52-Week Highs On Tuesday - benzinga.com Stocks That Hit 52-Week Highs On Wednesday
benzinga.com Stocks That Hit 52-Week Highs On Tuesday 
benzinga.com Stocks That Hit 52-Week Highs On Friday